AKT1 and ulcerative colitis: The mechanism of action may involve LD4-PDT mediating the expression of the AKT/IKK/NF-κB pathway and downstream inflammatory cytokines through AOC1. Consequently, LD4 has the potential to serve as a novel photosensitizer in the treatment of ulcerative colitis.